Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

The last team in the field and the subject of plenty of criticism the past two days, UNC put the hammer down early to win its ...

Work and Pensions Secretary Liz Kendall tried and failed to deflect criticism about PIPs from the Tories. Claims are rising ...

AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases.

The agency says it also will examine nutrients contained in formulas to ensure they "promote health and wellbeing during critical stages of development." Meanwhile, as the White House saps the Office ...

“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (3/18) Here's today's health policy haiku: ...

A small federal agency that plays a big role in trying to address America's mental health crisis is in trouble.

Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH ...